BDBM504300 3α,7α,11β-trihydroxy-6α-ethyl-24-nor-5β-cholan-23-oic acid ::US11034717, Compound 1

SMILES CC[C@H]1[C@@H](O)C2C3CC[C@H]([C@H](C)CC(O)=O)[C@@]3(C)C[C@H](O)C2[C@@]2(C)CC[C@@H](O)C[C@@H]12

InChI Key InChIKey=OOIQLCZZVNRNRT-OYLBSVCVSA-N

Data  1 EC50

Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 504300   

TargetRNA-binding protein FXR1(Human)
Intercept Pharmaceuticals, Inc.

US Patent
LigandPNGBDBM504300(3α,7α,11β-trihydroxy-6α-ethyl-...)
Show SMILES CC[C@H]1[C@@H](O)C2C3CC[C@H]([C@H](C)CC(O)=O)[C@@]3(C)C[C@H](O)C2[C@@]2(C)CC[C@@H](O)C[C@@H]12
Show InChI InChI=1S/C25H42O5/c1-5-15-18-11-14(26)8-9-24(18,3)22-19(27)12-25(4)16(13(2)10-20(28)29)6-7-17(25)21(22)23(15)30/h13-19,21-23,26-27,30H,5-12H2,1-4H3,(H,28,29)/t13-,14-,15-,16-,17?,18+,19+,21?,22?,23-,24+,25-/m1/s1
Affinity DataEC50:  680nMAssay Description:AlphaScreen was used with the aim of identifying novel modulators by taking advantage of the bimolecular interaction prevailing between FXR and the L...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid